The results of the major special projects of infectious disease prevention and control technology have been effective
The results of the major special projects of infectious disease prevention and control technology have been effective February 26, 2015 Source: Family Planning Commission In accordance with the "National Medium- and Long-Term Plan for Science and Technology Development Plan", the major science and technology project "Severe infectious diseases such as AIDS and viral hepatitis" was launched in August 2008. Specialized for the main battlefield of population health, aiming at the major needs of prevention and control of infectious diseases, focusing on AIDS, viral hepatitis, tuberculosis and new infectious diseases, we will strengthen the construction of prevention and control technology system, and develop a batch of diagnosis and treatment products and treatment plans. And preventive control strategies provide powerful technical support for improving the ability to prevent and control major and emerging infectious diseases.
Thymosin is a hormone secreted from the thymus. Its primary function is to stimulate the production of T cells, which are an important part of the immune system. Thymosin also assists in the development of B cells to plasma cells to produce antibodies. In addition to its role as a major actin-sequestering molecule, Thymosin Beta 4 plays a role in tissue repair.
Aicar Powder,Adipotide Powder,Dermorphin Powders,Bodybuilding Raw Powder Shaanxi YXchuang Biotechnology Co., Ltd , https://www.peptidenootropics.com
The ability to prevent and control acute infectious diseases continues to increase. In view of the severe situation of frequent occurrence of new infectious diseases in recent years, it is a key link to find out the epidemic situation, identify pathogens reliably, and effectively reduce death. The key technology and technical capacity support technology are strengthened. The “Network System for Preventing and Controlling New Epidemic Infectious Diseases Prevention and Control Technology†covering the whole country has been established. The emergency monitoring capability and the ability to confirm unknown pathogens have reached the international advanced level, and have played an important role in the response to major epidemics in recent years. Among them, the research on the prevention and treatment of influenza A (H1N1) was awarded the first prize of National Science and Technology Progress Award in 2014; the National Influenza Center became the only WHO influenza reference laboratory in developing countries.
The scientific and technological level of major infectious disease prevention and control has been significantly improved. A number of important achievements have been made in the fields of AIDS diagnosis and treatment, comprehensive intervention, hepatitis B new immunization strategy and severe hepatitis treatment, tuberculosis diagnosis and drug-resistant tuberculosis treatment, which provide strong support for reducing the "three diseases and two rates". For example, the development of HIV nucleic acid detection reagents has shortened the detection window from 22 days to 11 days. It has been applied to blood supply screening in some areas and achieved good results; early antiviral treatment intervention for people living with HIV, and their new healthy spouse The infection rate decreased by 73%; the successful development of 60 micrograms of hepatitis B vaccine increased the vaccination response rate from 78.6% to 92.8%; optimized the clinical treatment plan for chronic severe hepatitis, which reduced the mortality rate from 84.6% to 56.6%; successfully developed Mycobacterium tuberculosis Rapid detection of reagents will increase the detection rate by 20%; establish research and demonstration zones in some areas, and actively explore new modes of integrated science and technology prevention.
The ability of scientific and technological innovation continues to increase. Specially implement the innovation-driven development strategy, establish and improve the new national system and collaborative innovation network, aim at key technology bottlenecks, enhance the source innovation ability, and accelerate the transformation and application of results. By the end of 2014, the special achievements in infectious diseases had won 92 provincial and ministerial-level scientific and technological awards, including 15 national-level science and technology awards. We have established a multi-channel talent introduction and training system, and introduced a number of “Thousand Talents Programs†and overseas high-level talents.
In the next stage, the special project on infectious diseases will focus on the major needs of prevention and control, focus on the major needs of prevention and control, further highlight the key points, accelerate the process of scientific research and development and the promotion of results, and give full play to the leading role of scientific and technological innovation in accordance with the principle of focusing on key points, focusing on the long-term and focusing on the future. .